y 27632 has been researched along with vardenafil dihydrochloride in 2 studies
Studies (y 27632) | Trials (y 27632) | Recent Studies (post-2010) (y 27632) | Studies (vardenafil dihydrochloride) | Trials (vardenafil dihydrochloride) | Recent Studies (post-2010) (vardenafil dihydrochloride) |
---|---|---|---|---|---|
1,924 | 3 | 891 | 780 | 151 | 289 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albersen, M; Bivalacqua, TJ; Bollen, I; BrĂ´ne, B; De Ridder, DJ; Falter, M; Linsen, L; Sandner, P; Tinel, H; Uvin, P; Van der Aa, F; Van Renterghem, K; Weyne, E | 1 |
Thoma, C | 1 |
2 other study(ies) available for y 27632 and vardenafil dihydrochloride
Article | Year |
---|---|
Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Topics: Amides; Drug Synergism; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Middle Aged; Penis; Phosphodiesterase 5 Inhibitors; Pyridines; rho-Associated Kinases; Treatment Failure; Vardenafil Dihydrochloride | 2017 |
Erectile dysfunction: Too much ROCK - erection block.
Topics: Amides; Cyclic Nucleotide Phosphodiesterases, Type 5; Erectile Dysfunction; Humans; Male; Penile Erection; Phosphodiesterase 5 Inhibitors; Pyridines; rho-Associated Kinases; Vardenafil Dihydrochloride | 2017 |